# Efficacy of Memantine in Prevention of Oxaliplatin-induced Peripheral Neurotoxicity

> **NCT05834231** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Mansoura University** · enrollment: 60 (estimated)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** Memantine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05834231
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-08
- **Primary completion:** 2024-03
- **Final completion:** 2024-10
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05834231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05834231, "Efficacy of Memantine in Prevention of Oxaliplatin-induced Peripheral Neurotoxicity". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05834231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*